Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Publication/Presentation Date
1-1-2020
Abstract
INTRODUCTION: Glioblastoma (GBM) is the most common and lethal of the central nervous system (CNS) malignancies. The initiation, progression, and infiltration ability of GBMs are attributed in part to the dysregulation of microRNAs (miRNAs). Thus, targeting dysregulated miRNAs with RNA oligonucleotides (RNA interference, RNAi) has been proposed for GBM treatment. Despite promising results in the laboratory, RNA oligonucleotides have clinical limitations that include poor RNA stability and off-target effects. RNAi therapies against GBM confront an additional obstacle, as they need to cross the blood-brain barrier (BBB).
METHODS: Here, we developed gold-liposome nanoparticles conjugated with the brain targeting peptides apolipoprotein E (ApoE) and rabies virus glycoprotein (RVG). First, we functionalized gold nanoparticles with oligonucleotide miRNA inhibitors (OMIs), creating spherical nucleic acids (SNAs). Next, we encapsulated SNAs into ApoE, or RVG-conjugated liposomes, to obtain SNA-Liposome-ApoE and SNA-Liposome-RVG, respectively. We characterized each nanoparticle in terms of their size, charge, encapsulation efficiency, and delivery efficiency into U87 GBM cells in vitro. Then, they were administered intravenously (iv) in GBM syngeneic mice to evaluate their delivery efficiency to brain tumor tissue.
RESULTS: SNA-Liposomes of about 30-50 nm in diameter internalized U87 GBM cells and inhibited the expression of miRNA-92b, an aberrantly overexpressed miRNA in GBM cell lines and GBM tumors. Conjugating SNA-Liposomes with ApoE or RVG peptides increased their systemic delivery to the brain tumors of GBM syngeneic mice. SNA-Liposome-ApoE demonstrated to accumulate at higher extension in brain tumor tissues, when compared with non-treated controls, SNA-Liposomes, or SNA-Liposome-RVG.
DISCUSSION: SNA-Liposome-ApoE has the potential to advance the translation of miRNA-based therapies for GBM as well as other CNS disorders.
Volume
15
First Page
2809
Last Page
2828
ISSN
1178-2013
Published In/Presented At
Grafals-Ruiz, N., Rios-Vicil, C. I., Lozada-Delgado, E. L., Quiñones-Díaz, B. I., Noriega-Rivera, R. A., Martínez-Zayas, G., Santana-Rivera, Y., Santiago-Sánchez, G. S., Valiyeva, F., & Vivas-Mejía, P. E. (2020). Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma. International journal of nanomedicine, 15, 2809–2828. https://doi.org/10.2147/IJN.S241055
Disciplines
Medicine and Health Sciences
PubMedID
32368056
Department(s)
Department of Surgery, Department of Surgery Residents, Fellows and Residents
Document Type
Article